[HTML][HTML] The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis
C Tang, L Cui, Y Xu, L Xie, P Sun, C Liu, W Xia… - Scientific reports, 2016 - nature.com
It has been widely reported that the incidence and severity of Clostridium difficile infection (CDI)
have increased dramatically in North America and Europe. However, little is known …
have increased dramatically in North America and Europe. However, little is known …
Co-infection with respiratory pathogens among COVID-2019 cases
…, T Wu, K Zhao, Y Chen, B Wu, F Zhu, B Zhu, L Cui - Virus research, 2020 - Elsevier
Accumulating evidence shows that microbial co-infection increases the risk of disease
severity in humans. There have been few studies about SARS-CoV-2 co-infection with other …
severity in humans. There have been few studies about SARS-CoV-2 co-infection with other …
Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China
…, C Huang, Y Jiao, F Zhu, B Zhu, L Cui - The Journal of …, 2020 - academic.oup.com
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We investigated the serum …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We investigated the serum …
[HTML][HTML] Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
…, S Wu, J Zhu, H Pan, X Wang, Z Song, J Wan, L Cui… - Nature medicine, 2022 - nature.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
and the waning of vaccine-elicited neutralizing antibodies suggests that additional …
and the waning of vaccine-elicited neutralizing antibodies suggests that additional …
[HTML][HTML] An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
…, X Feng, Z Jiang, Y Wu, Y Chi, X Guo, L Cui… - Signal transduction and …, 2021 - nature.com
The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
requires an urgent need to find effective therapeutics for the treatment of coronavirus disease …
requires an urgent need to find effective therapeutics for the treatment of coronavirus disease …
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled …
…, G Zhong, J Chen, J Han, H Sun, L Cui… - The Lancet …, 2022 - thelancet.com
Background All currently available SARS-CoV-2 vaccines are administered by
intramuscular injection. We aimed to evaluate the safety and immunogenicity of a live-attenuated …
intramuscular injection. We aimed to evaluate the safety and immunogenicity of a live-attenuated …
Toilets dominate environmental detection of severe acute respiratory syndrome coronavirus 2 in a hospital
Respiratory and fecal aerosols play confirmed and suspected roles, respectively, in
transmitting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An extensive …
transmitting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An extensive …
[HTML][HTML] Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus
L Cui, D Liu, W Shi, J Pan, X Qi, X Li, X Guo… - Nature …, 2014 - nature.com
Influenza A (H7N9) virus has been causing human infections in China since February 2013,
raising serious concerns of potential pandemics. Previous studies demonstrate that human …
raising serious concerns of potential pandemics. Previous studies demonstrate that human …
[HTML][HTML] Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection
Y Qi, L Cui, Y Ge, Z Shi, K Zhao, X Guo, D Yang… - BMC infectious …, 2012 - Springer
Background Pulmonary tuberculosis (TB) is a highly lethal infectious disease and early
diagnosis of TB is critical for the control of disease progression. The objective of this study was to …
diagnosis of TB is critical for the control of disease progression. The objective of this study was to …
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV
…, K Liu, D Liu, X Guo, Y Ge, J Li, L Cui… - Journal of …, 2021 - Am Soc Microbiol
Among seven coronaviruses that infect humans, three (severe acute respiratory syndrome
coronavirus [SARS-CoV], Middle East respiratory syndrome coronavirus [MERS-CoV], and the …
coronavirus [SARS-CoV], Middle East respiratory syndrome coronavirus [MERS-CoV], and the …
